Literature DB >> 12504681

Regulation of protein kinases in insulin, growth factor and Wnt signalling.

Laurence H Pearl1, David Barford.   

Abstract

Protein kinase cascades provide the regulatory mechanisms for many of the essential processes in eukaryotic cells. Recent structural and biochemical work has revealed the basis of phosphorylation regulation of three consecutive protein kinases - phosphoinositide-dependent kinase 1 (PDK1), protein kinase B (PKB)/Akt and glycogen synthase kinase 3beta (GSK3beta) - which transduce signals generated by insulin and/or growth factors binding to cell surface receptors. PDK1 and PKB are both AGC family kinases. Whereas PKB is positively regulated via its phosphorylated C-terminal hydrophobic motif, the activity and specificity of PDK1 are determined by equivalent hydrophobic motifs of substrate AGC kinases. In a contrasting mechanism, GSK3beta is negatively regulated by competitive autoinhibition by its phosphorylated N terminus. GSK3beta also functions in the developmental Wnt signalling pathway, but without cross-talk with the PDK1-PKB/Akt pathway. Structural studies of GSK3beta complexes are contributing to our understanding of the phosphorylation-independent mechanism that insulates the Wnt and insulin/growth factor pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12504681     DOI: 10.1016/s0959-440x(02)00386-x

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  20 in total

1.  Allosteric activation of the protein kinase PDK1 with low molecular weight compounds.

Authors:  Matthias Engel; Valerie Hindie; Laura A Lopez-Garcia; Adriana Stroba; Francis Schaeffer; Iris Adrian; Jochen Imig; Leila Idrissova; Wolfgang Nastainczyk; Stefan Zeuzem; Pedro M Alzari; Rolf W Hartmann; Albrecht Piiper; Ricardo M Biondi
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

2.  Roles of Pdk1p, a fission yeast protein related to phosphoinositide-dependent protein kinase, in the regulation of mitosis and cytokinesis.

Authors:  Andrea Bimbó; Jianhua Liu; Mohan K Balasubramanian
Journal:  Mol Biol Cell       Date:  2005-04-27       Impact factor: 4.138

3.  R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.

Authors:  Jaideep Behari; Gang Zeng; Wade Otruba; Michael D Thompson; Peggy Muller; Amanda Micsenyi; Sandeep S Sekhon; Lorenzo Leoni; Satdarshan P S Monga
Journal:  J Hepatol       Date:  2006-12-21       Impact factor: 25.083

4.  Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.

Authors:  Valerie Hindie; Adriana Stroba; Hua Zhang; Laura A Lopez-Garcia; Leila Idrissova; Stefan Zeuzem; Daniel Hirschberg; Francis Schaeffer; Thomas J D Jørgensen; Matthias Engel; Pedro M Alzari; Ricardo M Biondi
Journal:  Nat Chem Biol       Date:  2009-08-30       Impact factor: 15.040

Review 5.  Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer.

Authors:  Sayem Miah; Charles A S Banks; Mark K Adams; Laurence Florens; Kiven E Lukong; Michael P Washburn
Journal:  Mol Biosyst       Date:  2016-12-20

6.  Discovery of SBF1 as an allosteric inhibitor targeting the PIF-pocket of 3-phosphoinositide-dependent protein kinase-1.

Authors:  Wei Liu; Pengfei Li; Ye Mei
Journal:  J Mol Model       Date:  2019-06-13       Impact factor: 1.810

7.  Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.

Authors:  Rüdiger Arnold; Irene M Patzak; Brit Neuhaus; Sadia Vancauwenbergh; André Veillette; Johan Van Lint; Friedemann Kiefer
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action.

Authors:  Atefeh Rabiee; Marcus Krüger; Jacob Ardenkjær-Larsen; C Ronald Kahn; Brice Emanuelli
Journal:  Cell Signal       Date:  2018-03-14       Impact factor: 4.315

Review 9.  Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Authors:  Rongshi Li; Alan Pourpak; Stephan W Morris
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

10.  Glycogen synthase kinase 3β inhibition promotes human iTreg differentiation and suppressive function.

Authors:  Yongxiang Xia; Han Zhuo; Yunjie Lu; Lei Deng; Runqiu Jiang; Long Zhang; Qin Zhu; Liyong Pu; Xuehao Wang; Ling Lu
Journal:  Immunol Res       Date:  2015-05       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.